US Launches Pharmaceutical Pricing Investigation into Germany, Raising Tariff Risks
The United States has initiated an investigation into Germany's pharmaceutical pricing policies, signalling potential trade friction that could escalate into tariffs. The move reflects broader American concerns about drug prices globally.